Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462195) titled 'Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Bach Mai Hospital

Condition: Thyroid Diseases

Intervention: Drug: Dexmedetomidine

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: March 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07462195

Disclaimer: Curated by HT Syndication....